The DNA Distortion
ANDE, a U.S. biotechnology company, promised a "faster way to a safer world" with its revolutionary rapid DNA testing machine. But by selling its innovation...
Showing 757 - 768 of 1862
Beijing Is Set to Rescue the Market Again: But Is That the Right Thing to Do?
There are much better ways for the government to spend hundreds of billions of dollars than propping up Chinese stocks.
Biotech Decoupling?
Plus, Victor Shih on China's stock markets.
The Rising Cost of the Climate Crisis
Besides the human cost, natural disasters are causing ever more damage to China’s economy.
Ernest Scheyder on the Tough Choices around Critical Minerals
The journalist discusses the trade-offs involved in sourcing the minerals needed to power the clean energy transition, and how the U.S. fell behind China in...
G42’s China Ties Reveal a Broader AI Debate
How far should the U.S. government go to ensure that adversaries like China can’t catch up on AI?
U.S. Technologies and the Emboldening of China
Rather than restricting access to militarily useful technologies, U.S. export control officials and their failed policies risk emboldening Beijing.
Comeback King?
Don't count Alibaba out yet.
Can Alibaba Deliver?
Eclipsed overseas by younger e-commerce rivals, Alibaba is relying on a little-known part of its business for its comeback. Cainiao, which focuses on the nitty-gritty...
Michael Rogers on China’s Cyber Threat
The head of U.S. Cyber Command under Presidents Obama and Trump on why it's been difficult to change China's behavior and the need for a...
The Dilemma of the China Shedding Strategy
Global investment firms face a risky balancing act as they create separate operations in China.
The E-Commerce War
Plus, China's cyber threat.